Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06370143 · ClinicalTrials.gov registry record
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
A clinical trial of Gastric Cancer and Gastric Adenocarcinoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 3,200
- Enrollment target
- 7
- Study locations
NCT06370143 is a study of Gastric Cancer and Gastric Adenocarcinoma that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 3,200 participants, above the 298-participant average among 153 other Gastric Cancer trials with a reported enrollment target (974% higher). The trial reports 7 study locations across 2 states.
The verdict
NCT06370143, a study of Gastric Cancer and Gastric Adenocarcinoma, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 3,200 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to create a registry of participants with precursor lesions for gastric cancer, including gastric atrophy, intestinal metaplasia, and dysplasia. Normal controls and individuals with gastric cancer for comparison of baseline characteristics will also be enrolled.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites) - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites) - Rockville Centre
New Jersey
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,200 participants |
| Start Date | 2024-04-11 |
| Est. Completion | 2036-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06370143
The ClinicalTrials.gov registry entry for NCT06370143 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 298-participant average among 153 other Gastric Cancer trials with a reported enrollment target (974% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Gastric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT06370143 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06370143 about?
NCT06370143 is a clinical study titled "A Study Collecting Health Information to Understand and Prevent Gastric Cancer". The purpose of this study is to create a registry of participants with precursor lesions for gastric cancer, including gastric atrophy, intestinal metaplasia, and dysplasia. Normal controls and individuals with gastric cancer for comparison of baseline characteristics will also be enrolled.
What is the current status of trial NCT06370143?
This trial is currently recruiting. The enrollment target is 3,200 participants. The study started on 2024-04-11. Estimated completion is 2036-04-11.
What conditions does trial NCT06370143 study?
This clinical trial studies the following conditions: Gastric Cancer, Gastric Adenocarcinoma, Dysplasia, Gastric Intestinal Metaplasia, Gastric Atrophy.
What interventions are being tested in trial NCT06370143?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT06370143?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06370143 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
RECRUITING · Phase 1
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.